- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-26-0182121

Sparshiv Pharmaceutical Private Limited
About Sparshiv Pharmaceutical Private Limited
Data last updated:
Sparshiv Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2021PTC204321. Its GSTIN is 27ABGCS8595N1Z9 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Sarika Santosh Mondle and Santosh Sahebrao Mondle.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G. No. 167 Balaji Compex Dhore Wasti Kesnand, Pune, Maharashtra, India – 412207.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.65 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹11,346 (net margin -1.3%) and EBITDA of -₹7,932 (EBITDA margin -0.9%).
Sparshiv Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0182121).
Company details
Recognitions & Rankings of Sparshiv Pharmaceutical
Contact details
Sparshiv Pharmaceutical Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressG. No. 167 Balaji Compex Dhore Wasti Kesnand, Pune, Maharashtra, India – 412207
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sparshiv Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sparshiv Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sparshiv Pharmaceutical Private Limited, buy the company report.
Financials of Sparshiv Pharmaceutical Private Limited
FY 2025 filings availableSparshiv Pharmaceutical Private Limited reported revenue of ₹8.65 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹7,932 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹11,346 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.9% | |||
| Net Profit Margin | -1.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sparshiv Pharmaceutical Private Limited, buy the company report.
Board of directors of Sparshiv Pharmaceutical Private Limited
Sparshiv Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarika Santosh Mondle | Director | 16 Sep 2021 | 5 Years 1 Months | Current |
| Santosh Sahebrao Mondle | Director | 16 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Sparshiv Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mamata Pulse Meditech Private Limited | ₹8.66 Lakh (FY 2023) | Bhubaneswar, Odisha, India | ||||
| Millets Pharmaceuticals Private Limited | ₹8.66 Lakh (FY 2024) | 6.0% | Jammu, Jammu and Kashmir, India | |||
| Kedaara Lifecare Solutions (OPC) Private Limited | ₹8.66 Lakh (FY 2025) | 14.0% | Bhopal, Madhya Pradesh, India | |||
| Antarnaad Health Services Private Limited | ₹8.65 Lakh (FY 2024) | 55.0% | New Delhi, Delhi, India | |||
| Gitisha Ayurvedic Clinic Private Limited | ₹8.65 Lakh (FY 2023) | -21.0% | Bhubaneswar, Odisha, India | |||
| Sparshiv Pharmaceutical Private Limitedthis company | ₹8.65 Lakh (FY 2025) | -₹11,346 | -1.3% | 6.0% | Pune, Maharashtra, India | |
| Saran Health Care Private Limited | ₹8.65 Lakh (FY 2025) | 12.0% | Chennai, Tamil Nadu, India | |||
| Venkatesha Scan Centre Private Limited | ₹8.64 Lakh (FY 2024) | -19.0% | Pandharpur, Maharashtra, India | |||
| Neosethu Healthcare Private Limited | ₹8.64 Lakh (FY 2022) | Bangalore, Karnataka, India | ||||
| BHM Welfare Foundation | ₹8.63 Lakh (FY 2022) | -43.0% | Kaithal, Haryana, India | |||
| Verocon Meditech Private Limited | ₹8.63 Lakh (FY 2020) | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Sparshiv Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sparshiv Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sparshiv Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sparshiv Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Sparshiv Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABGCS8595N1Z9 | Maharashtra | Active | 08 Jun 2022 |
To see the full GST registrations and return filing status of Sparshiv Pharmaceutical Private Limited, buy the company report.
Recent activity
Sparshiv Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Santosh Sahebrao Mondle was appointed as Director on 16 Sep 2021.
Frequently asked questions
Sparshiv Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 September 2021 (5+ years old) and is registered under CIN U51909PN2021PTC204321.
Sparshiv Pharmaceutical has 2 current directors:
- Sarika Santosh Mondle - Director
- Santosh Sahebrao Mondle - Director
The latest financial statements of Sparshiv Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Sparshiv Pharmaceutical is 27ABGCS8595N1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sparshiv Pharmaceutical is U51909PN2021PTC204321. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sparshiv Pharmaceutical was incorporated on 16 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Sparshiv Pharmaceutical by revenue are Mamata Pulse Meditech Private Limited, Millets Pharmaceuticals Private Limited, Kedaara Lifecare Solutions (OPC) Private Limited, Antarnaad Health Services Private Limited, Gitisha Ayurvedic Clinic Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Santosh Sahebrao Mondle was appointed as Director on 16 Sep 2021. Sarika Santosh Mondle was appointed as Director on 16 Sep 2021.
Yes, Sparshiv Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0182121).
The registered office of Sparshiv Pharmaceutical is at G. No. 167 Balaji Compex Dhore Wasti Kesnand, Pune, Maharashtra, India – 412207.
Sparshiv Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

